We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.03B
AUM Growth
-$253M
Cap. Flow
-$300M
Cap. Flow %
-29.18%
Top 10 Hldgs %
16.91%
Holding
2,102
New
716
Increased
301
Reduced
361
Closed
706

Sector Composition

Rank Sector Weight
1 Technology 10.3%
2 Financials 8.77%
3 Healthcare 8.31%
4 Consumer Discretionary 6.89%
5 Communication Services 5.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHUN icon
1301
Phunware
PHUN
$43.2M
$24K ﹤0.01%
+406
New +$28K
GNMX
1302
DELISTED
Aevi Genomic Medicine Inc
GNMX
$24K ﹤0.01%
161,612
+82,103
+103% +$11.2K
ATOS icon
1303
Atossa Therapeutics
ATOS
$23.6M
$23K ﹤0.01%
+980
New +$23K
CETX icon
1304
Cemtrex
CETX
$5.25M
0
PRSO icon
1305
Peraso
PRSO
$10.8M
$23K ﹤0.01%
+330
New +$26K
VANI icon
1306
Vivani Medical
VANI
$120M
$23K ﹤0.01%
1,292
+167
+15% +$3.28K
WHWK
1307
Whitehawk Therapeutics
WHWK
$266M
$23K ﹤0.01%
+2,470
New +$20.6K
BFX
1308
DELISTED
BowFlex Inc.
BFX
$23K ﹤0.01%
+13,387
New +$20.9K
TBLT
1309
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$23K ﹤0.01%
1
AXU
1310
DELISTED
Alexco Resource Corp
AXU
$23K ﹤0.01%
10,053
-172,953
-95% -$319K
PER
1311
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$23K ﹤0.01%
27,033
+15,456
+134% +$19.9K
HIND
1312
Vyome Holdings
HIND
$15.8M
0
SISI
1313
DELISTED
Shineco
SISI
0
NMTR
1314
DELISTED
9 Meters Biopharma
NMTR
$22K ﹤0.01%
1,997
+1,143
+134% +$19K
VIVE
1315
DELISTED
VIVEVE MED INC
VIVE
$22K ﹤0.01%
+1,748
New +$49.7K
HTGM
1316
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$22K ﹤0.01%
178
-17
-9% -$2.3K
ACET icon
1317
Adicet Bio
ACET
$77M
$21K ﹤0.01%
+125
New +$63.3K
TBHC
1318
DELISTED
The Brand House Collective
TBHC
$21K ﹤0.01%
+16,874
New +$22.6K
LWAY icon
1319
Lifeway Foods
LWAY
$454M
$21K ﹤0.01%
+10,437
New +$21.4K
PMTS icon
1320
CPI Card Group
PMTS
$352M
$21K ﹤0.01%
+23,008
New +$34.6K
SPHS
1321
DELISTED
Sophiris Bio, Inc.
SPHS
$21K ﹤0.01%
57,195
-2,274
-4% -$1.03K
GMO
1322
DELISTED
General Moly, Inc.
GMO
$20K ﹤0.01%
84,903
+58,957
+227% +$15.3K
INAP
1323
DELISTED
Internap Corporation
INAP
$20K ﹤0.01%
+17,739
New +$31.1K
FGP
1324
DELISTED
Ferrellgas Partners, L.P.
FGP
$20K ﹤0.01%
57,994
+44,300
+323% +$26.8K
RHE
1325
DELISTED
Regional Health Properties, Inc.
RHE
$20K ﹤0.01%
+14,349
New +$20.4K

Similar funds

Virtu Financial's Q4 2019 Portfolio in Review

As of Q4 2019, Virtu Financial held 2,102 positions worth $1.03B, down 20% from $1.28B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Virtu Financial withdrew a net $300M in Q4 2019, closing 706 positions and reducing 361 holdings. Its most notable exit was VanEck Junior Gold Miners ETF, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 6.6% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Virtu Financial opened a new position in iShares Core S&P 500 ETF worth $9.56M.

  • Virtu Financial's largest Q4 2019 buy was iShares Core S&P 500 ETF: 29,573 shares worth $9.56M.
  • Virtu Financial added most to iShares US Real Estate ETF in Q4 2019, an estimated $23.8M increase.
  • Virtu Financial's biggest Q4 2019 reduction was SPDR Gold Trust, cutting an estimated $78M.
  • Virtu Financial fully exited VanEck Junior Gold Miners ETF in Q4 2019, selling an estimated $25.2M.
  • Virtu Financial's ten largest holdings make up 17% of its $1.03B portfolio in Q4 2019.
  • Virtu Financial opened 716 new positions and closed 706 in Q4 2019.
  • Virtu Financial's portfolio value fell 20% quarter-over-quarter to $1.03B.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.